JPWO2021071977A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021071977A5
JPWO2021071977A5 JP2022520980A JP2022520980A JPWO2021071977A5 JP WO2021071977 A5 JPWO2021071977 A5 JP WO2021071977A5 JP 2022520980 A JP2022520980 A JP 2022520980A JP 2022520980 A JP2022520980 A JP 2022520980A JP WO2021071977 A5 JPWO2021071977 A5 JP WO2021071977A5
Authority
JP
Japan
Prior art keywords
item
agonist
antigen
glycero
palmitoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022520980A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022552200A5 (https=
JP2022552200A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054621 external-priority patent/WO2021071977A1/en
Publication of JP2022552200A publication Critical patent/JP2022552200A/ja
Publication of JP2022552200A5 publication Critical patent/JP2022552200A5/ja
Publication of JPWO2021071977A5 publication Critical patent/JPWO2021071977A5/ja
Pending legal-status Critical Current

Links

JP2022520980A 2019-10-07 2020-10-07 樹状細胞およびT細胞の活性化を増強するためのならびにTH-1免疫応答を誘導するためのin vitroの方法および組成物 Pending JP2022552200A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962912005P 2019-10-07 2019-10-07
US62/912,005 2019-10-07
PCT/US2020/054621 WO2021071977A1 (en) 2019-10-07 2020-10-07 In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response

Publications (3)

Publication Number Publication Date
JP2022552200A JP2022552200A (ja) 2022-12-15
JP2022552200A5 JP2022552200A5 (https=) 2023-10-18
JPWO2021071977A5 true JPWO2021071977A5 (https=) 2023-10-18

Family

ID=75437644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520980A Pending JP2022552200A (ja) 2019-10-07 2020-10-07 樹状細胞およびT細胞の活性化を増強するためのならびにTH-1免疫応答を誘導するためのin vitroの方法および組成物

Country Status (11)

Country Link
US (1) US20240122975A1 (https=)
EP (1) EP4041298A4 (https=)
JP (1) JP2022552200A (https=)
KR (1) KR20220098351A (https=)
CN (1) CN115461073A (https=)
AU (1) AU2020363707A1 (https=)
BR (1) BR112022006743A2 (https=)
CA (1) CA3157004A1 (https=)
IL (1) IL292009A (https=)
MX (1) MX2022004186A (https=)
WO (1) WO2021071977A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180318414A1 (en) 2015-01-12 2018-11-08 Children's Medical Center Corporation Pro-Inflammatory and Adjuvant Functions of Toll-Like Receptor 4 Antagonists
JP7753205B2 (ja) * 2019-11-18 2025-10-14 ザ・チルドレンズ・メデイカル・センター・コーポレーシヨン 超活性樹状細胞は養子細胞移植に基づく持続性抗腫瘍免疫を可能にする
WO2024151124A1 (ko) * 2023-01-12 2024-07-18 주식회사 이뮤노맥스 항암능이 우수한 기억 t 세포 유래 면역세포치료제의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1636229B (zh) * 2001-09-06 2012-12-19 西北生物治疗药物公司 引发单核树突细胞和t细胞th-1应答的组合物和方法
US20180318414A1 (en) * 2015-01-12 2018-11-08 Children's Medical Center Corporation Pro-Inflammatory and Adjuvant Functions of Toll-Like Receptor 4 Antagonists
CN107849537A (zh) * 2015-06-30 2018-03-27 西北生物治疗药物公司 诱发改善的或增加的抗肿瘤免疫应答的经最佳活化的树突细胞
JP6980650B2 (ja) * 2015-09-15 2021-12-15 ノースウエスト バイオセラピューティクス,インコーポレイティド 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法

Similar Documents

Publication Publication Date Title
Liau et al. Treatment of intracranial gliomas with bone marrow—derived dendritic cells pulsed with tumor antigens
Ashley et al. Bone marrow–generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors
Hegmans et al. Immunotherapy of murine malignant mesothelioma using tumor lysate–pulsed dendritic cells
ES2766299T3 (es) Composiciones y procedimientos para la activación linfocitaria de células dendríticas monocíticas y células T para generar una respuesta Th-1
JP5816627B2 (ja) 抗原特異的t細胞の増殖のための方法
JP4841794B2 (ja) ヒト樹状細胞による外因性抗原のクラスi提示を増加させる方法
RO120579B1 (ro) Utilizarea ligandului flt3
CN102782123B (zh) 用于抑制肿瘤细胞增殖的改进的组合物
WO2009040413A2 (en) An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
JP2024019229A (ja) 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法
CN115461073A (zh) 用于增强树突细胞和T细胞激活以及用于诱导Th-1免疫应答的体外方法和组合物
WO2004053095A2 (en) In situ maturation of dendritic cells
WO2002053176A2 (en) An autologous anti-cancer vaccine
JP2002509717A (ja) 抑制された単球由来細胞、それらの調製法及びそれらの医薬組成物における使用
AU2003246396B2 (en) A method for generating antigen-presenting cells
JPWO2021071977A5 (https=)
JP2002509715A (ja) 刺激された単球に由来する細胞、その調製及び用途
US20060073589A1 (en) Rapid generation of activated mononuclear antigen presenting cells from monocytes
HK40085184A (en) In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response
JP2002510642A (ja) ヒト患者における抗原提示細胞および抗腫瘍応答の増強法
US20170298083A1 (en) New immunostimulatory compounds
WO2016135286A1 (en) Method for stimulating dendritic cells (dcs)
Jacobs et al. Endocrine organs under the control of the immune system: potential implications for cellular therapies
Nazarkina et al. Preparation of dendritic cells for cancer immunotherapy
WO2016159286A1 (ja) 癌ワクチンの製造方法、及び癌ワクチン